Executive Chairman Sells $6.28M in Shares Following Option Exercise
ENVA has more than doubled off its 52-week low of $79.407 on elevated volume (2.7× avg).
Summary
Enova International's Executive Chairman, David Fisher, sold over $6.28 million in common stock after exercising options, reducing his direct holdings.
Key Events · Ownership and Investor Activity · ENVA
-
Executive Chairman Sells Shares
David Fisher, Executive Chairman, sold 37,989 shares of common stock for a total value of $6,280,151.54.
-
Option Exercise Precedes Sale
The sale followed the exercise of options to acquire 37,989 shares at an exercise price of $23.96, totaling $910,216.44.
-
Follows Prior Intent to Sell
This transaction executes the intent to sell previously disclosed in a Form 144 filed on January 30, 2026.
Analysis · ENVA · Finance
This Form 4 filing details the execution of a significant stock sale by Executive Chairman David Fisher, following his exercise of options. The sale of over $6.28 million in shares, which represents a notable portion of his direct holdings, follows a Form 144 filed on January 30, 2026, indicating his intent to sell a similar amount. While the option exercise increased his total shares, the subsequent open market sale results in a net disposition of shares, which can be interpreted as a negative signal regarding insider sentiment. Investors should note the timing of this sale, which occurred shortly after the company reported strong Q4 and full-year 2025 financial results on January 27, 2026.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1498 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ENVA was trading at $159.07 on NYSE in the Finance sector, with a market capitalization of approximately $3.9B. The 52-week trading range was $79.41 to $176.68. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.